Literature DB >> 23378597

Classification of the disorders of hemoglobin.

Bernard G Forget1, H Franklin Bunn.   

Abstract

Over the years, study of the disorders of hemoglobin has served as a paradigm for gaining insights into the cellular and molecular biology, as well as the pathophysiology, of inherited genetic disorders. To date, more than 1000 disorders of hemoglobin synthesis and/or structure have been identified and characterized. Study of these disorders has established the principle of how a mutant genotype can alter the function of the encoded protein, which in turn can lead to a distinct clinical phenotype. Genotype/phenotype correlations have provided important understanding of pathophysiological mechanisms of disease. Before presenting a brief overview of these disorders, we provide a summary of the structure and function of hemoglobin, along with the mechanism of assembly of its subunits, as background for the rationale and basis of the different categories of disorders in the classification.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23378597      PMCID: PMC3552344          DOI: 10.1101/cshperspect.a011684

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  22 in total

1.  Hemoglobin Bart's disease in an Italian boy. Interaction between alpha-thalassemia and hereditary persistence of fetal hemoglobin.

Authors:  D H Chui; M Patterson; C E Dowling; H H Kazazian; A G Kendall
Journal:  N Engl J Med       Date:  1990-07-19       Impact factor: 91.245

Review 2.  The natural history of sickle cell disease.

Authors:  Graham R Serjeant
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

3.  Modulation of fetal hemoglobin synthesis by iron deficiency.

Authors:  J G Adams; M B Coleman; J Hayes; W T Morrison; M H Steinberg
Journal:  N Engl J Med       Date:  1985-11-28       Impact factor: 91.245

4.  Effects of increased anionic charge in the beta-globin chain on assembly of hemoglobin in vitro.

Authors:  K Adachi; T Yamaguchi; J Pang; S Surrey
Journal:  Blood       Date:  1998-02-15       Impact factor: 22.113

Review 5.  Subunit assembly of hemoglobin: an important determinant of hematologic phenotype.

Authors:  H F Bunn
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

6.  Electrostatic interactions in the assembly of haemoglobin.

Authors:  H F Bunn; M J McDonald
Journal:  Nature       Date:  1983 Dec 1-7       Impact factor: 49.962

7.  Molecular mechanism of AHSP-mediated stabilization of alpha-hemoglobin.

Authors:  Liang Feng; David A Gell; Suiping Zhou; Lichuan Gu; Yi Kong; Jianqing Li; Min Hu; Nieng Yan; Christopher Lee; Anne M Rich; Robert S Armstrong; Peter A Lay; Andrew J Gow; Mitchell J Weiss; Joel P Mackay; Yigong Shi
Journal:  Cell       Date:  2004-11-24       Impact factor: 41.582

8.  HbS-oman heterozygote: a new dominant sickle syndrome.

Authors:  R L Nagel; S Daar; J R Romero; S M Suzuka; D Gravell; E Bouhassira; R S Schwartz; M E Fabry; R Krishnamoorthy
Journal:  Blood       Date:  1998-12-01       Impact factor: 22.113

9.  Electrostatic attraction governs the dimer assembly of human hemoglobin.

Authors:  N T Mrabet; M J McDonald; S Turci; R Sarkar; A Szabo; H F Bunn
Journal:  J Biol Chem       Date:  1986-04-15       Impact factor: 5.157

10.  An abundant erythroid protein that stabilizes free alpha-haemoglobin.

Authors:  Anthony J Kihm; Yi Kong; Wei Hong; J Eric Russell; Susan Rouda; Kazuhiko Adachi; M Celeste Simon; Gerd A Blobel; Mitchell J Weiss
Journal:  Nature       Date:  2002-06-13       Impact factor: 49.962

View more
  29 in total

1.  The Interplay between Molten Globules and Heme Disassociation Defines Human Hemoglobin Disassembly.

Authors:  Premila P Samuel; Mark A White; William C Ou; David A Case; George N Phillips; John S Olson
Journal:  Biophys J       Date:  2020-02-04       Impact factor: 4.033

2.  Mitophagy is increased during erythroid differentiation in β-thalassemia.

Authors:  Limei Wu; Wei Xu; Luhong Xu; Qian Kong; Jianpei Fang
Journal:  Int J Hematol       Date:  2016-10-28       Impact factor: 2.490

Review 3.  HbE/β-Thalassemia and Oxidative Stress: The Key to Pathophysiological Mechanisms and Novel Therapeutics.

Authors:  Rhoda Elison Hirsch; Nathawut Sibmooh; Suthat Fucharoen; Joel M Friedman
Journal:  Antioxid Redox Signal       Date:  2016-11-28       Impact factor: 8.401

Review 4.  Clinical applications of molecular genetic discoveries.

Authors:  Ali J Marian
Journal:  Transl Res       Date:  2015-10-24       Impact factor: 7.012

5.  Supplemental oxygen therapy recommendations in patients with sickle cell disease during air travel: A cross-sectional survey of North American health care providers.

Authors:  Amarjot Padda; Catherine Corriveau-Bourque; Mark Belletrutti; Aisha A K Bruce
Journal:  Paediatr Child Health       Date:  2019-04-23       Impact factor: 2.253

6.  Discovery of DS79932728: A Potent, Orally Available G9a/GLP Inhibitor for Treating β-Thalassemia and Sickle Cell Disease.

Authors:  Katsushi Katayama; Ken Ishii; Hideki Terashima; Eisuke Tsuda; Makoto Suzuki; Keiichi Yotsumoto; Kumiko Hiramoto; Isao Yasumatsu; Munefumi Torihata; Takashi Ishiyama; Tsuyoshi Muto; Takahiro Katagiri
Journal:  ACS Med Chem Lett       Date:  2020-12-28       Impact factor: 4.345

7.  The compound state: Hb S/beta-thalassemia.

Authors:  Maria Stella Figueiredo
Journal:  Rev Bras Hematol Hemoter       Date:  2015-03-14

Review 8.  Sickle Hepatopathy.

Authors:  Dibya L Praharaj; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2020-08-09

Review 9.  Genome-based therapeutic interventions for β-type hemoglobinopathies.

Authors:  Kariofyllis Karamperis; Maria T Tsoumpeli; Fotios Kounelis; Maria Koromina; Christina Mitropoulou; Catia Moutinho; George P Patrinos
Journal:  Hum Genomics       Date:  2021-06-05       Impact factor: 4.639

10.  Methemoglobin formation in mutant hemoglobin α chains: electron transfer parameters and rates.

Authors:  Vaibhav A Dixit; Jochen Blumberger; Shivam Kumar Vyas
Journal:  Biophys J       Date:  2021-07-13       Impact factor: 3.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.